Ledger.Open graph →

SEC Form D · filed April 6, 2023

INVO Bioscience, Inc

Offering

$3.0M

Sold

$3.0M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

SARASOTA, FL

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Matthew Szot · Sarasota, FLDirector Rebecca Messina · Sarasota, FLDirector Steven Shum · Sarasota, FLExec · Director Barbara Ryan · Sarasota, FLDirector Andrea Goren · Sarasota, FLExec Trent Davis · Sarasota, FLDirector Michael J. Campbell · Sarasota, FLExec Jennifer L. Bercy · Woodland Hills, CADirector Emre Altinok · Brooklyn, NYDirector David K. Hiemstra · Houston, TXDirector David E. Kass · Columbus, OHExec Adrian Waters · Dublin 2, IrelandDirector David Andonian · New York, NYExec · Director Victor Kuznetsov · FORT LAUDERDALE, FLExec Brett Paulk · Tomball, TXExec · Director John Galdieri Iii · ANNAPOLIS, MDExec Patrick Britton-Harr · ANNAPOLIS, MDDirector Wenyi Huang · Dallas, TXDirector Jon Bridgman · Toronto, Ontario, CanadaExec Guillaume Luccisano · Cambridge, MADirector Richard A. Western · Atlanta, GADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗